ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
99,197.85
-5.23%
S&P 500
6,101.24
-0.29%
Dow Jones
44,424.25
-0.32%
US Dollar vs Yen
154.61
-0.89%
Brent Oil
77.785
0.78%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE

  6. Alligator Bioscience Ab (0RK9) 銘柄情報

Alligator Bioscience Ab

Alligator Bioscience Ab (0RK9)

LSE
23.00
0.00
( 0.00% )
更新日時： 09:00:00
15分遅延

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
23.00
買値
0.00
売値
0.00
出来高
0.00
0.00 日の範囲 0.00
23.00 52 週間の範囲 23.00
時価総額
15.133B
前日終値
23.00
始値
-
時刻
(O)
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
14,339
発行済株式数
657,954,000
配当利回り
-
PER
-1.27
1 株当たり利益 (EPS)
-0.38
歳入
59.27M
純利益
-248.59M

Alligator Bioscience Ab について

セクター
Noncomml Resh Organizations
業界
Noncomml Resh Organizations
ウェブサイト
www.alligatorbioscience.se
本社
Lund, Swe
設立
-
Alligator Bioscience Ab is listed in the Noncomml Resh Organizations sector of the ロンドン証券取引所 with ticker 0RK9. The last closing price for Alligator Bioscience Ab was SEK23. Over the last year, Alligator Bioscience Ab shares have traded in a share price range of SEK 23.00 to SEK 23.00.

Alligator Bioscience Ab currently has 657,954,000 shares in issue. The market capitalisation of Alligator Bioscience Ab is SEK15.13 billion. Alligator Bioscience Ab has a price to earnings ratio (PE ratio) of -1.27.

0RK9 最新ニュース

その他のニュース

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

2022年4月1日
PR Newswire (US)

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

2022年4月1日
PR Newswire (US)

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

2022年3月23日
PR Newswire (US)

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

2022年3月23日
PR Newswire (US)

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

2022年2月11日
PR Newswire (US)

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

2022年2月11日
PR Newswire (US)

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

2022年2月1日
PR Newswire (US)

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

2022年2月1日
PR Newswire (US)

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

2022年1月19日
PR Newswire (US)

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

2022年1月19日
PR Newswire (US)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1002323235987623DE
4002323231575723DE
12002323231433923DE
2600232323699823DE
5200232323392423DE
15600232323240623DE
26000232323225523DE

0RK9 - Frequently Asked Questions (FAQ)

What is the current Alligator Bioscience Ab share price?
The current share price of Alligator Bioscience Ab is SEK 23.00
How many Alligator Bioscience Ab shares are in issue?
Alligator Bioscience Ab has 657,954,000 shares in issue
What is the market cap of Alligator Bioscience Ab?
The market capitalisation of Alligator Bioscience Ab is SEK 15.13B
What is the 1 year trading range for Alligator Bioscience Ab share price?
Alligator Bioscience Ab has traded in the range of SEK 23.00 to SEK 23.00 during the past year
What is the PE ratio of Alligator Bioscience Ab?
The price to earnings ratio of Alligator Bioscience Ab is -1.27
What is the cash to sales ratio of Alligator Bioscience Ab?
The cash to sales ratio of Alligator Bioscience Ab is 5.33
What is the reporting currency for Alligator Bioscience Ab?
Alligator Bioscience Ab reports financial results in SEK
What is the latest annual turnover for Alligator Bioscience Ab?
The latest annual turnover of Alligator Bioscience Ab is SEK 59.27M
What is the latest annual profit for Alligator Bioscience Ab?
The latest annual profit of Alligator Bioscience Ab is SEK -248.59M
What is the registered address of Alligator Bioscience Ab?
The registered address for Alligator Bioscience Ab is MEDICON VILLAGE, SCHEELEVAGEN 2, LUND, 223 81
What is the Alligator Bioscience Ab website address?
The website address for Alligator Bioscience Ab is www.alligatorbioscience.se
Which industry sector does Alligator Bioscience Ab operate in?
Alligator Bioscience Ab operates in the NONCOMML RESH ORGANIZATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VASTVast Resources Plc
0.175p
(25.00%)
71.61M
GOODGood Energy Group Plc
480.00p
(21.52%)
340.1k
IMMImmupharma Plc
4.73p
(16.79%)
9.2M
CHFChesterfield Resources Plc
0.35p
(15.89%)
115k
DKEDukemount Capital Plc
0.039p
(14.71%)
84.12M
GENIGenincode Plc
3.95p
(-17.71%)
812.51k
SYMESupply@me Capital Plc
0.0025p
(-13.79%)
65.28M
OBIOndine Biomedical Inc.
11.25p
(-11.76%)
854.01k
AWEAlphawave Ip Group Plc
134.80p
(-11.32%)
865.63k
WBIWoodbois Limited
0.10p
(-11.11%)
40.77M
UKOGUk Oil & Gas Plc
0.0215p
(0.00%)
569.99M
TRPTower Resources Plc
0.03p
(1.69%)
106.01M
INSPInspirit Energy Holdings Plc
0.0025p
(4.17%)
85.2M
DKEDukemount Capital Plc
0.039p
(14.71%)
84.12M
VASTVast Resources Plc
0.175p
(25.00%)
71.61M

議論

フィード全体を表示

最近閲覧した銘柄

LSE
0RK9
Alligator Bioscience Ab
LSE
0DNT
Aurskog Sparebank
LSE
0MVK
Augros Cosmetic Packaging
LSE
0R9D
Aeroporto Guglielmo Marc...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有